Evaluation of adverse event clusters following immunization with mRNA COVID-19 vaccines: a real-world analysis using EudraVigilance data

First published 16/09/2021

Last updated 05/06/2025

EU PAS number:

EUPAS43083

Study

Ongoing

Documents

Study protocol

Study results

Study Results | Frontiers in Medicine Journal

English (7.73 MB - PDF)View document

Study report

Other information

Publications

Study publications

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

EUPAS43083-43229

English (95.92 KB - PDF)View document

Composition of steering group and observers

EUPAS43083-43230

English (155.05 KB - PDF)View document

Secondary tabs